Thomas M. Rose has helped U.S. and international businesses, issuers and investment banks negotiate and close billions of dollars in cross-border financings, including a “Pharmaceutical Deal of the Year.” For Tom, teamwork is the essential ingredient for success in complex deals. Tom is an exceptionally experienced lawyer who concentrates his practice on U.S. cross-border securities and corporate law matters.
With a particular focus on U.S.-Canada activity, every year he and his team advise clients with respect to financing transactions totaling billions of dollars – regularly landing them among the top performers on Thomson Reuters’ annual league tables and recently earning the “Pharmaceutical Deal of the Year” Atlas Award from Global M&A Network.
Tom’s services adapt and grow along with the needs of his clients. He represents U.S. and foreign issuers and investment banks in a broad range of public and private financings, including financings under the U.S.-Canada Multijurisdictional Disclosure System (MJDS), other cross-border public offerings, and U.S.-foreign private placements.
Tom also advises U.S. and foreign issuers with respect to the U.S. securities and corporate law aspects of mergers and acquisition transactions, including portfolio company roll-ups, as well as in connection with litigation arising from such deals.
Tom counsels U.S. and foreign issuers in connection with initial listings on the New York Stock Exchange (NYSE), the NYSE MKT and the Nasdaq Stock Market (NASDAQ).
He also helps clients ensure compliance with ongoing U.S. reporting and corporate governance requirements under U.S. federal securities laws and exchange rules, and acts as a principal American liaison (PAL) on the over-the-counter (OTC) international markets.
- George Washington University, J.D., 1999
- Northwestern University, B.A., 1994
BAR ADMISSIONS : Virginia, District of Columbia
Professional and Community Involvement :
- Virginia Bar Association
- American Bar Association
- District Columbia Bar Association
Rate : $$$$